Evidence map›Paper›PMID 31025136›Full record

ArticleJournal of industrial microbiology & biotechnology2019

Correction to: High-yield production of L-serine from glycerol by engineered Escherichia coli.

Xiaomei Zhang, Dong Zhang, Jiafen Zhu, Wang Liu, Guoqiang Xu, Xiaojuan Zhang, Jinsong Shi, Zhenghong Xu

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xiaomei ZhangLaboratory of Pharmaceutical Engineering, School of Pharmaceutics Science, Jiangnan University, Wuxi, People's Republic of China.
Dong ZhangLaboratory of Pharmaceutical Engineering, School of Pharmaceutics Science, Jiangnan University, Wuxi, People's Republic of China.
Jiafen ZhuLaboratory of Pharmaceutical Engineering, School of Pharmaceutics Science, Jiangnan University, Wuxi, People's Republic of China.
Wang LiuLaboratory of Pharmaceutical Engineering, School of Pharmaceutics Science, Jiangnan University, Wuxi, People's Republic of China.
Guoqiang XuNational Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Xiaojuan ZhangNational Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Jinsong ShiLaboratory of Pharmaceutical Engineering, School of Pharmaceutics Science, Jiangnan University, Wuxi, People's Republic of China.
Zhenghong XuNational Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi, 214122, People's Republic of China. zhenghxu@jiangnan.edu.cn.
Jiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unfortunately, the order of the figures 1-4 has been positioned wrongly in the print published article.

Identifiers

PMID31025136
OpenAlexW2940767022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.